Table 3

Characteristics of lesions evaluated for tumor growth rate (TGR)

OverallIrradiated lesionsNon-irradiated lesionsWilcoxon p value
Patients (n)121212
Lesions (n) (sum)371324
Lesions (n) (median (IQR))3.00 (2.00 to 4.00)1.00 (1.00 to 1.00)2.00 (1.00 to 3.00)0.008
Sum of diameters prebaseline (median (IQR))95.17 (60.58)36.00 (24.75 to 48.50)36.50 (15.25 to 101.50)0.817
Sum of diameters baseline (median (IQR))102.67 (60.70)34.00 (25.00 to 49.00)53.00 (15.75 to 104.00)0.583
Sum of diameters at first evaluation (median (IQR))77.08 (60.42)20.50 (14.75 to 35.75)35.50 (13.25 to 66.50)0.436
REF.period (median (IQR))1.23 (0.90 to 1.65)1.23 (0.90 to 1.65)1.23 (0.90 to 1.65)1.000
EXP.period (median (IQR))2.97 (2.91 to 3.20)2.97 (2.91 to 3.20)2.97 (2.91 to 3.20)1.000
REF-TGR (median (IQR))35.40 (79.01)6.47 (−8.78 to 43.15)20.17 (2.62 to 62.98)0.271
EXP-TGR (median (IQR))−26.32 (30.03)−34.32 (−57.97 to −13.91)−22.44 (−51.61 to −2.01)0.603
TGR.diff (median (IQR))−61.72 (91.73)−52.16 (−84.54 to −13.62)−60.03 (−106.76 to −14.14)0.817
  • REF-TGR corresponds to TGR before the start of the treatment. EXP-TGR corresponds to TGR between the start of the treatment and the first evaluation (at 3 months).